Top 10 Consumer Service Companies To Own For 2015

Top 10 Consumer Service Companies To Own For 2015: Enzymotec Ltd (ENZY)

Enzymotec Ltd., incorporated on March 08, 1998, is engaged in manufacturing of ingredients and medical foods company. Its technologies, research, and clinical validation process enables the Company to develop differentiated solutions across a variety of products. The Company markets its product portfolio primarily to established global consumer companies and target large and growing consumer health and wellness markets. Its clinically validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases. The Company operates in two segments: Nutrition and VAYA Pharma. In addition to its existing products, the Company has several other products to address additional indications in the development phase. enzyme processes; lipid modification; lipid analysis; and process technology and development.

Nutrition

The Companys Nutrition segment develops and manufactures nutritional ingre dient products based on lipids, such as phospholipids, which form the structural basis of cell membranes and are easily recognized, incorporated and used by the body. Its customer base for this segment includes formula and nutritional supplement companies such as Biostime and IVC. Its two selling nutritional ingredient products are InFat, a clinically-proven fat ingredient for infant formula, and krill oil. Its other products in this segment are targeted at improving brain health and providing benefits in memory, learning abilities and concentration.

VAYA Pharma

VAYA Pharma, develops, manufactures and sells branded, prescription-only medical foods for the dietary management of patients with certain medical conditions or diseases having special, medically determined nutrient requirements. Although medical foods must be safe and effective as demonstrated in human clinical studies, they do not require the same expensive and time co! nsuming regulatory ap proval process typical of prescription drugs. In addition to! its existing products, it has several other products to address additional indications in the development phase.

Advisors' Opinion:

• [By Victor Selva]

  Finally, as opposed to what we just discussed, the firm is currently Zacks Rank # 4Sell, and it also has a longer-term recommendation of Neutral. A Sell rating indicates that the stock, over the next 1 to 3 months, will perform at an annualized rate of 4.8%, which is not attractive for investors. For investors looking for a Strong Buy Rank, BioLife Solutions, Inc. (BLFS) and Enzymotec Ltd. (ENZY) could be the options.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-consumer-service-companies-to-own-for-2015.html